Latest AI and machine learning research in geriatrics for healthcare professionals.
Machine learning applied to neuroimaging can help with medical diagnosis and early detection by identifying biomarkers of subtle changes in brain structure and function. The effectiveness of advanced diffusion MRI (dMRI) imaging methods for pre-dementia classification remains largely unexplored, particularly when combined with CSF biomarkers. We implemented XGBoost machine learning models to evalu...
Neurodegenerative diseases are characterized by complex proteins misfolded that propagate within the brain. For instance, current findings highlight the role of 2 specific misfolded proteins in Alzheimer which are believed to spread using brain fibers as highways. Previous studies investigated such spreading by simulation models or machine learning-based predictors which adopt the brain connectome...
Adjuvant use of bone-modifying agents (BMAs) to early-stage breast cancer (eBC) aims to maintain bone density, leading to prevention of bone metastasi...
Alzheimer’s disease (AD) and AD-related dementias (ADRD) exhibit heterogeneous progression rates, with rapid progression (RP) posing significant chall...
Positron Emission Tomography (PET) scans are a crucial tool in the diagnosing and monitoring of a number of complex conditions, including cancer, hear...
Alzheimer’s disease (AD) and Schizophrenia (SCZ) exhibit overlapping clinical features and biological mechanisms, but the extent of their shared genet...
Machine learning has emerged as a valuable tool in precision medicine and aging research. Here, we introduce the autonomic age gap, a novel metric qua...
Metabolic biomarkers can potentially be used for early diagnosis, prognostic risk stratification and/or early treatment and prevention of individuals ...
Long COVID, also referred to as post-acute sequelae of COVID-19 (PASC), is a substantial global health concern estimated to have affected over 145 mil...
The TOMM40’523 poly-T repeat polymorphism (rs10524523), located in the TOMM40 gene and in linkage disequilibrium with APOE, has been associated with c...
Alzheimer’s disease (AD), particularly late-onset AD, stands as the most prevalent neurodegenerative disorder globally. Owing to its substantial herit...
GM1 gangliosidosis is an inherited, progressive, and fatal neurodegenerative lysosomal storage disorder with no approved treatment. We calculated a pr...
Medication information is crucial for clinical routine and research. However, a vast amount is stored in unstructured text, such as doctoral letters, ...
Predicting the early onset of dementia due to Alzheimer’s Disease (AD) has major implications for timely clinical management and outcomes. Current dia...
Dementia with Lewy bodies (DLB) is frequently misdiagnosed as Alzheimer’s disease (AD) due to overlapping clinical presentations. In this study, we ev...
Amid efforts to understand spaceflight associated neuro-ocular syndrome (SANS), uncovering the role of the choroid in its etiology is challenged by th...
Primary age-related tauopathy (PART) and Alzheimer’s disease (AD) share hippocampal phospho-tau (p-tau) pathology but differ in ß-amyloid burden and d...
Accurate identification of patients at high risk of in-hospital mortality in intensive care units (ICUs) is vital for enhancing clinical decision-maki...
Training complex models on Alzheimer’s Disease (AD) datasets is challenging due to the costly process of extracting features from a wide range of pati...
Application of Large Language Models (LLMs) powered Conversation Agents (CAs) in healthcare has been evaluated using medical question-answering (QA) d...